NCR3 and cancer: Moreover, low MHC-class I expression and expression of NK ligands have been described for some cancer stem cells,39,40 suggesting an advantage of innate-like NKp30+CD8+ T cells to target cancer initiating cells that became invisible to T cell recognition.